Income statement, balance sheet and cash flow statement for the last 8 fiscal years, taken from the XBRL data PolyPid Ltd. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2018
FY2020
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Research and development
12.6
14.1
17
30.6
28
16.1
22.8
23.8
Selling and marketing
2.98
2.89
1.2
0.95
1.98
General and administrative
5.27
3.59
7.7
9.61
8.01
5.52
4.27
7.18
Operating income
-18.4
-18.6
-26.3
-43.1
-38.9
-22.9
-28
-33
Interest expense
1.02
1.62
1.51
0.87
Interest income
0.13
0.06
0.47
0.47
0.27
0.55
0.44
0.52
Other non-operating income
24.3
11.7
-10.6
0.54
-0.54
-0.93
-0.95
-0.69
Pre-tax income
36.9
-42.6
-39.4
-23.8
-29
-34.2
Income tax
0.13
0.07
0.04
0.01
Net income
5.92
-6.91
-36.9
-42.6
-39.6
-23.9
-29
-34.2
EBITDA
-18
-17.6
-25.3
-42
-37.2
-21
-26.4
-31.5
EPS, basic
-4.79
709.35
134.15
68.27
61.09
16.99
4.91
2.09
EPS, diluted
25.75
709.35
134.15
68.27
61.09
16.93
4.91
2.09
Shares, basic (weighted)
0.02
0.02
0.32
0.62
0.65
1.4
5.91
16.4
Shares, diluted (weighted)
0.02
0.02
0.32
0.62
0.65
1.42
5.91
16.4
Balance sheet
FY2018
FY2020
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
7.77
3.92
4.32
9.82
8.55
5.31
15.6
6.4
Other current assets
1.09
0.46
0.27
0.03
Total current assets
27.4
47.2
34.8
14.2
6.07
16.6
15.2
Property, plant and equipment
6.12
5.89
8.76
9.25
7.62
6.08
5.09
Lease right-of-use assets
2.43
1.6
2.3
1.68
Long-term investments
6.35
28.6
9.42
11.8
9.31
Other non-current assets
0.23
0.64
0.66
0.1
0.09
0.28
0.31
Total assets
33.8
75.8
44.2
26
15.4
25.2
22.3
Accounts payable
1.58
0.97
4.14
1.14
0.77
2.41
2.86
Accrued liabilities
0.32
0.68
1.79
1.25
1
1.46
0.35
Short-term debt
4.02
4
6.79
0.99
Total current liabilities
2.58
2.88
8.08
8.55
7.29
12.7
7.74
Long-term debt
7.57
6.38
0.63
Lease liabilities
1.17
0.86
1.28
0.65
Other non-current liabilities
0.01
0.01
0.02
0.4
0.4
0.4
Total liabilities
121
3.07
8.28
20.1
17.5
17.5
11.3
Total debt
4.02
10.4
7.42
0.99
Paid-in capital
5.67
205
211
220
236
275
312
Retained earnings
-93.3
-132
-175
-214
-238
-267
-302
Shareholders' equity
-81.7
-87.6
72.8
36
5.83
-2.1
7.68
11
Total equity
-81.7
-87.6
72.8
36
5.83
-2.1
7.68
11
Total liabilities and equity
33.8
75.8
44.2
26
15.4
25.2
22.3
Shares outstanding
0.02
0.62
18.8
0.67
1.65
10.2
18.2
Cash flow statement
FY2018
FY2020
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-5.92
-6.91
-36.9
-42.6
-39.6
-23.9
-29
-34.2
Depreciation and amortization
0.41
0.95
1.01
1.12
1.72
1.82
1.62
1.46
Stock-based compensation
1
0.98
4.58
4.75
4.31
3.39
2.82
4.85
Cash from operations
-16.7
-17.4
-21.6
-32.4
-34.3
-17.2
-22
-27.9
Capital expenditures
-3.07
-0.88
-0.78
-2.65
-1.77
-0.2
-0.08
-0.21
Purchases of investments
-8
-7
-18.6
-21.4
-26.2
Cash from investing
11
-23.6
-40.8
36.9
16.6
3.8
-0.33
-6.7
Debt issued
11.7
Debt repaid
-0.4
-2.62
-3.32
-6.38
Stock issued
0.02
0.01
0
0.4
4.42
8.72
0.53
Cash from financing
9.39
37.7
62.8
1.03
16.4
9.98
32.4
25.4
Net change in cash
3.67
-3.27
0.41
5.55
-1.31
-3.46
10.1
-9.21
Free cash flow
-19.8
-18.2
-22.4
-35
-36.1
-17.4
-22
-28.1
Interest paid
0.73
1.04
0.95
0.56
Income taxes paid
0.01
0.02
0
0.01
Key metrics
Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $5.22 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Return on equity (ROE)
-366.3%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-143.8%
Net income / average total assets.
Return on invested capital (ROIC)
-1,037.0%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Growth
Metric
Value
How it is calculated
EPS growth, 1y
-57.4%
EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y
-67.5%
Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y
-56.5%
Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y
42.8%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
23.5%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y
-31.5%
Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
-11.6%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-4.9%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
-21.7%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
176.5%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
193.4%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
119.6%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
1.97x
Current assets / current liabilities.
Quick ratio
0.83x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.83x
(Cash + short-term investments) / current liabilities.
Debt / equity
0.09x
Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets
4.4%
Total debt / total assets.
Liabilities / assets
50.8%
Total liabilities / total assets.
Net debt
-$5.4M
Total debt - cash - short-term investments. Negative means more cash than debt.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic
$2.09
Net income per basic share, as reported (split-adjusted).
FCF per share
-$1.72
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$1.70
Cash from operations / diluted weighted shares.
Book value per share
$0.60
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/B
9.66x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
9.66x
Market cap / tangible book value, when positive.
FCF yield
-26.5%
Free cash flow / market cap.
Earnings yield
-32.2%
Net income / market cap (the inverse of P/E).
Was PolyPid Ltd. profitable in fiscal 2025?
No. It reported a net loss of $34.2M.
How much free cash flow did PolyPid Ltd. generate in fiscal 2025?
Cash from operations of $27.9M minus capital expenditures of $210.0K left free cash flow of -$28.1M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.